The Claim
Neuropeptide Y levels are negatively correlated with heart rate variability markers of parasympathetic tone, including RMSSD and SDNN INDEX, in individuals with ventricular premature beats.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher levels of neuropeptide Y are associated with lower heart rate variability, indicating reduced parasympathetic nervous system activity in people with ventricular premature beats.
See the scientific wording
Neuropeptide Y levels are negatively correlated with heart rate variability (HRV) markers of parasympathetic tone, including RMSSD (r=-0.162, p=0.012) and SDNN INDEX (r=-0.136, p=0.037), suggesting elevated NPY is associated with reduced vagal activity in individuals with ventricular premature beats.
When stress increases, nerve cells in the heart release a chemical called Neuropeptide Y along with adrenaline. This chemical binds to receptors on heart muscle cells, making them more excitable and harder to calm down. At the same time, it reduces the activity of the nerve system that slows the heart rate. This imbalance causes the heart to beat irregularly and reduces the natural variation in heartbeats that reflects calm, restful control.
What the research says
1 studyStudy: The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats
This study found that people with higher levels of a stress-related chemical called NPY tend to have lower heart rate variability, which means their heart’s calming system isn’t working as well. So yes, more NPY is linked to less heart calmness.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.